This inventor holds 1 USPTO granted patent. Top assignee: Perspective Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dulanjali Thennakoon and Targeted Therapeutics
Introduction
Dulanjali Thennakoon is an inventor based in Seattle, Washington. His patent work includes research into compounds targeting the cholecystokinin-2 receptor, a focus relevant to the development of targeted therapeutic approaches.
Latest Patents
Thennakoon is associated with 1 patent: “Cholecystokinin-2 Receptor Targeted Compounds and Use Thereof.” The patent concerns compounds directed at the cholecystokinin-2 receptor and their potential uses.
Career Highlights
Thennakoon is associated with Perspective Therapeutics, Inc. His listed patent reflects work in receptor-targeted compounds and therapeutic research.
Collaborations
Dijie Liu and Mengshi Li are identified as Thennakoon’s coworkers. Their shared professional context connects them to the broader research and development environment at Perspective Therapeutics.
Conclusion
Dulanjali Thennakoon’s patent activity centers on cholecystokinin-2 receptor-targeted compounds, highlighting his contribution to therapeutic innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile